Related Experiment Video
Updated: Aug 14, 2026

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors
Published on: March 22, 2011
Viral infections and pediatric liver transplantation
1University of Pittsburgh School of Medicine, Division of Allergy, Immunology and Infectious Diseases, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA. greenm@chplink.chp.edu
Abstract:
Viral infections remain an important cause of morbidity and mortality following LTx in children. Increasing experience with both 'donor-associated' and 'community-acquired' viruses is leading to improved outcomes and the development of effective preventive strategies. The potential importance of emerging viral pathogens is an area of active research, which hopefully will also lead to effective treatments and potential preventive strategies for these newly recognized pathogens.
Insights
Viral infections cause significant illness and death in children after liver transplants (LTx). Improved management of known viruses and research into new ones are enhancing patient outcomes and prevention strategies.
Area of Science:
- Pediatric Hepatology
- Transplant Infectious Diseases
- Virology
Background:
- Viral infections are a major complication in pediatric liver transplant (LTx) recipients, contributing to significant morbidity and mortality.
- Management strategies for both donor-associated and community-acquired viruses have advanced.
- The emergence of novel viral pathogens poses an ongoing challenge in this population.
Purpose of the Study:
- To review the current understanding of viral infections following pediatric liver transplantation.
- To highlight advancements in the prevention and treatment of viral infections in LTx recipients.
- To discuss the implications of emerging viral pathogens in pediatric liver transplant care.
Main Methods:
- Literature review of viral infections in pediatric liver transplant patients.
- Analysis of current data on viral epidemiology and clinical outcomes.
- Discussion of established and emerging viral pathogens and their management.
Main Results:
- Increased clinical experience has led to improved outcomes for children undergoing LTx.
- Effective preventive strategies are being developed for common viral infections.
- Ongoing research is crucial for understanding and managing newly recognized viral pathogens.
Conclusions:
- Optimized management of viral infections is critical for improving survival rates in pediatric liver transplant recipients.
- Continued research into emerging viral threats is necessary to develop future treatments and preventive measures.
- A comprehensive approach to viral surveillance and management is essential in pediatric LTx programs.
More Related Videos
11:18Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
Published on: May 7, 2012
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Cytomegalovirus Disease
Hepatitis
Viral Hepatitis I: Introduction